Compare ABRDN Physical Gold Shares ETF (SGOL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ABRDN Physical Gold Shares ETF vs GeneDx Holdings Corp — how do they compare? ABRDN Physical Gold Shares ETF trades at $41.7, while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). Which is the better fit depends on your goals.
| SGOL | WGS | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Technology |
52-Week High | $51.41 | $167.51 |
52-Week Low | $34.68 | $34.51 |
Market Cap | — | $2.58B |
Enterprise Value | — | $2.61B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SGOL is currently trading at $41.48, down 1.78% over the past 24 hours amid broader market volatility. The technical picture shows bearish momentum with moving averages signaling selling pressure, though oversold RSI conditions suggest potential for near-term stabilization. Recent news highlights strong institutional gold demand and positive analyst price targets despite current price weakness.
The outlook remains constructive with major banks forecasting gold price appreciation to $4,900-$5,600 by year-end, though near-term volatility persists due to Fed policy uncertainty and geopolitical tensions. Key risks include interest rate sensitivity and dollar strength, while institutional accumulation provides underlying support.
WGS trades at $85.87, down 0.14% on the day, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4 million, beating estimates, and achieved adjusted profitability ahead of schedule. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics, driving positive sentiment.
Outlook is cautiously optimistic due to strong analyst support (90.9% buy ratings) and revenue growth, but risks include negative net income margins, high valuation multiples, and ongoing class action lawsuits. The stock's upside potential hinges on sustained operational improvements and market expansion in genomics diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
